These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 38300334

  • 1. Topographic analysis of local OCT biomarkers which predict progression to atrophy in age-related macular degeneration.
    Manafi N, Mahmoudi A, Emamverdi M, Corradetti G, Corona ST, Wykoff CC, Sadda SR.
    Graefes Arch Clin Exp Ophthalmol; 2024 Jul; 262(7):2083-2091. PubMed ID: 38300334
    [Abstract] [Full Text] [Related]

  • 2. OCT Risk Factors for Development of Atrophy in Eyes with Intermediate Age-Related Macular Degeneration.
    Hirabayashi K, Yu HJ, Wakatsuki Y, Marion KM, Wykoff CC, Sadda SR.
    Ophthalmol Retina; 2023 Mar; 7(3):253-260. PubMed ID: 36208726
    [Abstract] [Full Text] [Related]

  • 3. Acquired Vitelliform Lesions in Intermediate Age-Related Macular Degeneration: A Cross Sectional Study.
    Lindenberg S, Mahmoudi A, Oncel D, Corradetti G, Oncel D, Emamverdi M, Almidani L, Farahani A, Wakatsuki Y, He Y, Saju M S, Lee WK, Wykoff CC, Sarraf D, Freund KB, Sadda SR.
    Ophthalmol Retina; 2024 Sep; 8(9):854-862. PubMed ID: 38631656
    [Abstract] [Full Text] [Related]

  • 4. Bilateral evolution of OCT biomarkers in dry AMD: Long-term follow up study.
    Samanta A, Arora S, Jhingan M, Singh S, Amarasekera S, Tucci D, Cagini C, Lupidi M, Chhablani J.
    Eur J Ophthalmol; 2024 May; 34(3):683-690. PubMed ID: 37787166
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Drusen ooze: Predictor for progression of dry age-related macular degeneration.
    Jhingan M, Singh SR, Samanta A, Arora S, Tucci D, Amarasekera S, Cagini C, Lupidi M, Chhablani J.
    Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2687-2694. PubMed ID: 33710471
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. OCT risk factors for 2-year foveal involvement in non-treated eyes with extrafoveal geographic atrophy and AMD.
    Borrelli E, Barresi C, Berni A, Viggiano P, Reibaldi M, Introini U, Bandello F.
    Graefes Arch Clin Exp Ophthalmol; 2024 Jul; 262(7):2101-2109. PubMed ID: 38326629
    [Abstract] [Full Text] [Related]

  • 19. Progressive Choriocapillaris Changes on Optical Coherence Tomography Angiography Correlate With Stage Progression in AMD.
    Romano F, Ding X, Yuan M, Vingopoulos F, Garg I, Choi H, Alvarez R, Tracy JH, Finn M, Ravazi P, Stettler IVM, Laìns I, Vavvas DG, Husain D, Miller JW, Miller JB.
    Invest Ophthalmol Vis Sci; 2024 Jul 01; 65(8):21. PubMed ID: 38990069
    [Abstract] [Full Text] [Related]

  • 20. Geographic Atrophy in AMD: Prognostic Factors Based on Long-Term Follow-Up.
    Cedro L, Hoffmann L, Hatz K.
    Ophthalmic Res; 2023 Jul 01; 66(1):791-800. PubMed ID: 37231906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.